BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
      • Artificial intelligence
    • Coronavirus
    • Israel
    • IVDs on the rise
    • Radiopharmaceuticals
    • Rise of obesity
    • Top Biopharma Trends of 2023
    • Top Med-tech Trends of 2023
    • Top Preclinical Trends of 2023
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, January 31, 2024
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Other News To Note

July 9, 2003
No Comments

Other News To Note

June 26, 2003
No Comments

Other News To Note

June 25, 2003
No Comments

Other News To Note

May 30, 2003
No Comments

Other News To Note

May 28, 2003
No Comments

Other News To Note

May 22, 2003
No Comments

Other News To Note

May 21, 2003
No Comments

Other News To Note

May 20, 2003
No Comments

Other News To Note

May 15, 2003
No Comments

Other News To Note

May 14, 2003
No Comments
Previous 1 2 … 521 522 523 524 525 526 527 528 529 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan. 30, 2024.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for January 30, 2024.
  • 3D rendering of drug linked to antibody

    Corbus rockets on early clinical data for next-gen Nectin-4 ADC candidate

    BioWorld
    Shares of Corbus Pharmaceuticals Inc. (NASDAQ:CRBP) doubled on opening Jan. 26 and ended the day up a whopping 249% as investors got a look at data from a...
  • Hand holding 2024 with up arrows

    Following JPM, 2024 outlook ranges from hopeful to cautious

    BioWorld
    Setting the tone for the biopharma industry as it enters a new year, the J.P. Morgan Healthcare Conference (JPM) held each January has once again led to...
  • Tempest Therapeutics presents new TREX1 inhibitors for cancer

    BioWorld Science
    Tempest Therapeutics Inc. has divulged three-prime repair exonuclease 1 (TREX1) inhibitors reported to be useful for the treatment of cancer.

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2024. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing